Vita Life Sciences Ltd

ASX:VLS (Australia)  
A$ 2.29 (+1.33%) May 6
13.79
P/B:
2.98
Market Cap:
A$ 125.98M ($ 83.53M)
Enterprise V:
A$ 101.74M ($ 67.45M)
Volume:
503.00
Avg Vol (2M):
59.21K
Volume:
503.00
Avg Vol (2M):
59.21K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Vita Life Sciences Ltd ( ASX:VLS ) from 2007 to May 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Vita Life Sciences stock (ASX:VLS) PE ratio as of May 06 2024 is 13.79. More Details

Vita Life Sciences Ltd (ASX:VLS) PE Ratio (TTM) Chart

To

Vita Life Sciences Ltd (ASX:VLS) PE Ratio (TTM) Historical Data

Total 1240
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Vita Life Sciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-06 13.8 2024-03-01 13.2
2024-05-03 13.6 2024-02-29 12.9
2024-05-02 13.7 2024-02-28 13.3
2024-05-01 13.8 2024-02-27 13.3
2024-04-30 13.1 2024-02-26 13.3
2024-04-29 13.3 2024-02-23 11.3
2024-04-26 13.5 2024-02-22 11.4
2024-04-24 12.9 2024-02-21 11.7
2024-04-23 13.3 2024-02-20 11.7
2024-04-22 14.0 2024-02-19 11.9
2024-04-19 14.2 2024-02-16 11.8
2024-04-18 14.5 2024-02-15 11.8
2024-04-17 14.6 2024-02-14 11.4
2024-04-16 14.1 2024-02-13 11.4
2024-04-15 14.0 2024-02-12 11.8
2024-04-12 13.9 2024-02-09 11.8
2024-04-11 14.3 2024-02-08 11.4
2024-04-10 14.5 2024-02-07 11.5
2024-04-09 13.7 2024-02-06 11.4
2024-04-08 13.7 2024-02-05 11.4
2024-04-05 13.9 2024-02-02 11.4
2024-04-04 14.7 2024-02-01 11.4
2024-04-03 14.7 2024-01-31 11.4
2024-04-02 14.7 2024-01-30 11.4
2024-04-01 14.6 2024-01-29 11.4
2024-03-29 14.6 2024-01-26 11.1
2024-03-28 14.6 2024-01-25 11.1
2024-03-27 14.7 2024-01-24 11.1
2024-03-26 14.5 2024-01-23 10.7
2024-03-25 14.8 2024-01-22 10.7
2024-03-22 14.8 2024-01-19 10.6
2024-03-21 14.3 2024-01-18 10.4
2024-03-20 14.2 2024-01-17 10.4
2024-03-19 13.9 2024-01-16 10.4
2024-03-18 14.8 2024-01-15 11.4
2024-03-15 14.2 2024-01-12 11.4
2024-03-14 14.2 2024-01-11 11.4
2024-03-13 13.6 2024-01-10 11.4
2024-03-12 13.6 2024-01-09 11.4
2024-03-11 13.6 2024-01-08 11.3
2024-03-08 13.6 2024-01-05 11.3
2024-03-07 13.2 2024-01-04 11.3
2024-03-06 13.3 2024-01-03 11.3
2024-03-05 13.3 2024-01-02 11.1
2024-03-04 13.4 2024-01-01 10.7

Vita Life Sciences Ltd (ASX:VLS) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.